Evidence map›Paper›PMID 29848777›Full record

ArticleMolecular pharmacology2018

Novel Paradigms Governing

Mohammed M Nooh, Salvatore Mancarella, Suleiman W Bahouth

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. β-Adrenergic Receptors: Not Always Outside-In.Physiology (Bethesda, Md.) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. β-blockers Reverse Agonist-Induced βInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mohammed M NoohDepartments of Pharmacology (M.M.N., S.W.B.) and Physiology (S.M.), The University of Tennessee Health Sciences Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy Cairo University, Cairo, Egypt (M.M.N.).
Salvatore MancarellaDepartments of Pharmacology (M.M.N., S.W.B.) and Physiology (S.M.), The University of Tennessee Health Sciences Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy Cairo University, Cairo, Egypt (M.M.N.).
Suleiman W BahouthDepartments of Pharmacology (M.M.N., S.W.B.) and Physiology (S.M.), The University of Tennessee Health Sciences Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy Cairo University, Cairo, Egypt (M.M.N.) sbahouth@uthsc.edu.
University of Tennessee Health Science Center · USCairo University · EG

Funding

PKA targeting: A novel mechanism for GPCR resensitizationR01HL085848 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BAHOUTH, SULEIMAN WAKIM · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL085848
6 · The paper itself

Abstract

The

Indexed as

Adrenergic beta-1 Receptor AgonistsAdrenergic beta-1 Receptor AntagonistsAlprenololAnimalsCell MembraneCells, CulturedHumansIsoproterenolMyocytes, CardiacProtein TransportRatsReceptors, Adrenergic, beta-1ADRB1 protein, humanAdrenergic beta-1 Receptor AgonistsAdrenergic beta-1 Receptor AntagonistsAlprenololIsoproterenolReceptors, Adrenergic, beta-1

Identifiers

PMID29848777
PMCPMC6022806
OpenAlexW2806353651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.